Publications by Ana Lucia Azevedo Salgado

Publications by authors named "Ana Lucia Azevedo Salgado"

Page 1 of 1

N-ACETYLCYSTEINE AND/OR URSODEOXYCHOLIC ACID ASSOCIATED WITH METFORMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL MULTICENTER RANDOMIZED CONTROLLED TRIAL.

Claudia P Oliveira Helma P Cotrim Jose Tadeu Stefano Ana Cristina G Siqueira Ana Lucia Azevedo Salgado

Arq Gastroenterol

August 2019

Background: Nowadays, pharmacological treatment of non-alcoholic fatty liver disease (NAFLD) is still limited and it is based on the treatment of conditions associated comorbities. Oxidative stress and insulin resistance are the mechanisms that seem to be mostly involved in its pathogenesis.

Objective: To evaluate the efficacy of N-acetylcysteine (NAC) in combination with metformin (MTF) and/or ursodeoxycholic acid (UDCA) for treatment of non-alcoholic steatohepatitis (NASH).

View Article and Find Full Text PDF

- Ana Lucia Azevedo Salgado's recent research focuses on the pharmacological treatment of non-alcoholic fatty liver disease (NAFLD), particularly exploring the role of oxidative stress and insulin resistance in its pathogenesis
- Her study investigates the efficacy of N-acetylcysteine (NAC) in combination with metformin and/or ursodeoxycholic acid for treating non-alcoholic steatohepatitis (NASH) through an open-label multicenter randomized controlled trial
- The findings from her research contribute valuable insights into developing more effective treatments for NAFLD, emphasizing the need for targeted therapies addressing the underlying mechanisms of the disease

Publications by authors named "Ana Lucia Azevedo Salgado"

N-ACETYLCYSTEINE AND/OR URSODEOXYCHOLIC ACID ASSOCIATED WITH METFORMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL MULTICENTER RANDOMIZED CONTROLLED TRIAL.

Synopsis of recent research by authors named "Ana Lucia Azevedo Salgado"